EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.

Biotechnology

Health Care

Therapeutics

EpiBiologics

Craig Lichtenstein

Shyra Gardai

Isaac J. Rondon

The Leadership Team at EpiBiologics spearheads strategic decision-making, oversees organizational operations, drives scientific innovation, and manages business development to ensure the company's success in developing pioneering antibody-based therapies.

Leadership Team

About

Team members

Other teams at EpiBiologics

Scientific Team